| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |